Line 63: | Line 63: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | Head on over to our <a href="https://www.instagram.com/nusgem2018/">team Instagram</a> to enjoy snippets of our enjoyable time in iGEM 2018. | |
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
Line 74: | Line 74: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | Check out our <a href="https://igem.org/2018_Judging_Form?id=2819">Judging Form</a> to find out more about the prize and medal criteria our project has successfully accomplished. | |
<ul> | <ul> | ||
<li>#1 Wiki</a></li> | <li>#1 Wiki</a></li> | ||
Line 90: | Line 90: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | Check out our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Attributions">Attributions </a>page to find out more about the behind-the-scenes work - we are so excited to share more about the work that we have done, and credit the selfless individuals and organisations that have helped our team! | |
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
Line 102: | Line 102: | ||
Finish one of these two options: | Finish one of these two options: | ||
<ol> | <ol> | ||
− | <li> | + | <li>Take a look at our <a href="https://2018.igem.org/Team:NUS_Singapore-A/InterLab">InterLab </a>study page to find out more about our team’s contributions to the InterLab Measurement Study. |
</li> | </li> | ||
Line 124: | Line 124: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | Find out more about our team’s newly-designed and unique parts - a <a href="http://parts.igem.org/Part:BBa_K2819118">stress-reporter</a>, <a href="http://parts.igem.org/Part:BBa_K2819206">flavone synthase production induced by arabinose</a> for the production of apigenin, and the coding sequence necessary for <a href="http://parts.igem.org/Part:BBa_K2819000">eriodyctiol production</a>. | |
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
Line 135: | Line 135: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | In the spirit of international collaboration, check out our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Collaborations">Collaboration </a>page to learn more about the exciting developments that have transpired between NUSGEM and other iGEM teams! We are also pleased to present to you our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Collaborative_Report">Collaborative Report</a>, a joint initiative between <a href="https://2018.igem.org/Team:Toulouse-INSA-UPS"Team Toulouse-INSA-UPS 2018</a> and <a href="https://2018.igem.org/Team:ULaval/Team">Team ULaval 2018</a>. | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
</td> | </td> | ||
</tr> | </tr> | ||
+ | |||
<tr> | <tr> | ||
Line 153: | Line 148: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | No project exists in isolation, and Coup Dy’Etat is no exception - issues surrounding our project must be carefully considered to create a thoughtful and responsible design. Head to our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Human_Practices">Human Practices</a> page to find out how our team has engaged with stakeholders in the biomanufacturing and fashion industries, and to find out what we have learnt through our series of expert interviews. | |
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
Line 171: | Line 166: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | Through thoughtful engagement with stakeholders in the biomanufacturing and fashion industries, we have elucidated their concerns and suggestions, and integrated them into the design of our project and its overall direction. Find out more about how our project goals and direction were shaped by the integration of stakeholder suggestions at our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Human_Practices">Human Practices</a> page - this ensured our platform remained valuable and useful. | |
+ | |||
+ | Head on to our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Public_Engagement">Education and Public Engagement</a> page to learn more about how we engaged students and educators in fruitful and meaningful discussions about the ethics and applications of synthetic biology. | ||
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
Line 181: | Line 178: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | Our team embarked to improve upon a <a href="http://parts.igem.org/Part:BBa_K2332021">blue-light repressible circuit produced in 2017</a>. Find out more about <a href="http://parts.igem.org/Part:BBa_K2819103">our new and improved blue-light repressible promoter</a> that comes with a reporter and degradation tag. | |
+ | |||
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
Line 198: | Line 196: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | Our wet-lab and modelling sub-teams worked closely with each other. Head over to our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Model">Modelling</a> page to find out more about the development of our models, the data we used, and how our models have affected our system design. | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> | ||
Line 216: | Line 207: | ||
<tr> | <tr> | ||
<td class="description"> | <td class="description"> | ||
− | + | To check out the various milestones in our platform development, visit our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Demonstrate">Demonstrate </a>page. Our system works under safe and practical conditions - find out more on our <a href="https://2018.igem.org/Team:NUS_Singapore-A/Safety">Safety</a> page. | |
+ | |||
</td> | </td> | ||
<td><i class="fa fa-check tick" aria-hidden="true"></i> | <td><i class="fa fa-check tick" aria-hidden="true"></i> |
Revision as of 21:48, 16 October 2018
CONNECT WITH US
THE BRONZE CRITERIA
Register for iGEM, have a great iGEM season, and attend the Giant Jamboree. |
|
---|---|
Head on over to our team Instagram to enjoy snippets of our enjoyable time in iGEM 2018. | |
Competition Deliverables |
|
Check out our Judging Form to find out more about the prize and medal criteria our project has successfully accomplished.
|
|
Attributions |
|
Check out our Attributions page to find out more about the behind-the-scenes work - we are so excited to share more about the work that we have done, and credit the selfless individuals and organisations that have helped our team! | |
Characterization / Contribution |
|
Finish one of these two options:
|
THE SILVER CRITERIA
Validated Part |
|
---|---|
Find out more about our team’s newly-designed and unique parts - a stress-reporter, flavone synthase production induced by arabinose for the production of apigenin, and the coding sequence necessary for eriodyctiol production. | |
Collaboration |
|
In the spirit of international collaboration, check out our Collaboration page to learn more about the exciting developments that have transpired between NUSGEM and other iGEM teams! We are also pleased to present to you our Collaborative Report, a joint initiative between and Team ULaval 2018. | |
Human practice |
|
No project exists in isolation, and Coup Dy’Etat is no exception - issues surrounding our project must be carefully considered to create a thoughtful and responsible design. Head to our Human Practices page to find out how our team has engaged with stakeholders in the biomanufacturing and fashion industries, and to find out what we have learnt through our series of expert interviews. |
THE GOLD CRITERIA
Integrated Human Practices |
|
---|---|
Through thoughtful engagement with stakeholders in the biomanufacturing and fashion industries, we have elucidated their concerns and suggestions, and integrated them into the design of our project and its overall direction. Find out more about how our project goals and direction were shaped by the integration of stakeholder suggestions at our Human Practices page - this ensured our platform remained valuable and useful. Head on to our Education and Public Engagement page to learn more about how we engaged students and educators in fruitful and meaningful discussions about the ethics and applications of synthetic biology. | |
Improve a previous part or project |
|
Our team embarked to improve upon a blue-light repressible circuit produced in 2017. Find out more about our new and improved blue-light repressible promoter that comes with a reporter and degradation tag. | |
Clearly document the experimental characterization on the Part's Main Page on the Registry for both the existing and new parts (see this page for details). The Main Pages of each part's Registry entry must link to each other. The existing part must NOT be from your 2018 part number range and must be different from the part you used in Bronze #4. The new part must be different from the new part documented for Silver #1. Submit a sample of the new part to the iGEM Parts Registry (following the Registry submission requirements). | |
Modelling |
|
Our wet-lab and modelling sub-teams worked closely with each other. Head over to our Modelling page to find out more about the development of our models, the data we used, and how our models have affected our system design. | |
Demonstration |
|
To check out the various milestones in our platform development, visit our Demonstrate page. Our system works under safe and practical conditions - find out more on our Safety page. |